Myomo, Inc. (MYO) Quick Ratio
- Quick ratio · latest quarter: Value (m); Formula and calculation Cash, cash equivalents, current marketable securities and trade receivables / current liabilities. Period ending 2026-06-30..
Quick ratio
Overview →Financial period ending 2026-06-30; current quote (m). Amounts retain their stated periods and units.
| Metric | Value | Formula and calculation |
|---|---|---|
| Quick ratio · latest quarter | (m) | Cash, cash equivalents, current marketable securities and trade receivables / current liabilities. Period ending 2026-06-30. Calculation unavailable: missing inputs remain (m). |
Calculation inputs
| Input | Amount with unit | Raw financial data |
|---|---|---|
| Cash, securities and trade receivables | (m) | Cash and Cash Equivalents, at Carrying Value · Accounts Receivable, after Allowance for Credit Loss, Current |
| Current obligations | 10.61M USD | Liabilities, Current |
| Cash and equivalents | 11.22M USD | Cash and Cash Equivalents, at Carrying Value |
| Short-term securities | (m) | |
| Customer receivables | 4.95M USD | Accounts Receivable, after Allowance for Credit Loss, Current |
| Inventory · excluded from quick assets | 3.17M USD | Inventory, Net |
Calculated history
Changes compare with the next older row (previous quarter), unless explicitly labeled otherwise. Rolling 12-month growth compares two successive quarter-end rolling totals; it is not year-over-year growth.
| Period ending | Cash, securities and trade receivables (USD) | Current obligations (USD) | Cash and equivalents (USD) | Short-term securities (USD) | Customer receivables (USD) | Inventory · excluded from quick assets (USD) | Quick ratio |
|---|---|---|---|---|---|---|---|
| 2026-06-30 | (m) | $10.61M | $11.22M | (m) | $4.95M | $3.17M | (m) |
| 2026-03-31 | (m) | $9.39M | $11.40M | (m) | $4.82M | $3.55M | (m) |
| 2025-12-31 | (m) | $8.35M | $14.13M | (m) | $4.10M | $3.12M | (m) |
| 2025-09-30 | (m) | $9.20M | $12.55M | (m) | $5.29M | $3.65M | (m) |
| 2025-06-30 | (m) | $11.75M | $14.24M | (m) | $7.05M | $4.13M | (m) |
| 2025-03-31 | (m) | $11.68M | $19.79M | (m) | $4.66M | $3.37M | (m) |
| 2024-12-31 | (m) | $10.17M | $24.37M | (m) | $3.83M | $3.17M | (m) |
| 2024-09-30 | (m) | $6.99M | $6.62M | (m) | $3.73M | $3.38M | (m) |
| 2024-06-30 | (m) | $6.47M | $5.85M | (m) | $2.53M | $2.60M | (m) |
| 2024-03-31 | (m) | $5.56M | $5.43M | (m) | $1.68M | $2.39M | (m) |
| 2023-12-31 | (m) | $5.48M | $6.87M | (m) | $2.38M | $1.80M | (m) |
| 2023-09-30 | (m) | $5.78M | $6.91M | (m) | $2.52M | $1.48M | (m) |
| 2023-06-30 | (m) | $4.34M | $6.01M | (m) | $1.64M | $1.34M | (m) |
| 2023-03-31 | (m) | $3.93M | $9.26M | (m) | $1.55M | $1.57M | (m) |
| 2022-12-31 | (m) | $3.60M | $5.35M | (m) | $1.90M | $1.40M | (m) |
| 2022-09-30 | (m) | $4.11M | $7.42M | (m) | $1.60M | $1.48M | (m) |
| 2022-06-30 | (m) | $3.88M | $10.24M | (m) | $1.36M | $1.26M | (m) |
| 2022-03-31 | (m) | $4.65M | $12.94M | (m) | $1.69M | $1.03M | (m) |
| 2021-12-31 | (m) | $4.28M | $15.52M | (m) | $1.96M | $808.31K | (m) |
| 2021-09-30 | (m) | $3.72M | $12.61M | (m) | $2.22M | $644.14K | (m) |
| 2021-06-30 | (m) | $3.22M | $13.77M | (m) | $1.13M | $728.64K | (m) |
| 2021-03-31 | (m) | $4.10M | $17.37M | (m) | $765.23K | $793.79K | (m) |
| 2020-12-31 | (m) | $2.87M | $12.24M | (m) | $924.92K | $707.11K | (m) |
| 2020-09-30 | (m) | $2.21M | $13.32M | (m) | $308.52K | $759.80K | (m) |
| 2020-06-30 | (m) | $2.69M | $10.73M | (m) | $310.52K | $678.91K | (m) |
| 2020-03-31 | (m) | $4.13M | $13.73M | (m) | $299.29K | $602.88K | (m) |
| 2019-12-31 | (m) | $3.88M | $4.47M | (m) | $424.29K | $439.53K | (m) |
| 2019-09-30 | (m) | $1.66M | $4.33M | (m) | $134.01K | $454.38K | (m) |
| 2019-06-30 | (m) | $1.44M | $6.67M | (m) | $331.01K | $349.20K | (m) |
| 2019-03-31 | (m) | $1.58M | $9.23M | (m) | $399.89K | $301.28K | (m) |
| 2018-12-31 | (m) | $1.86M | $6.54M | (m) | $382.26K | $256.15K | (m) |
| 2018-09-30 | (m) | $1.88M | $9.09M | (m) | $352.82K | $272.66K | (m) |
| 2018-06-30 | (m) | $1.57M | $11.68M | (m) | $384.95K | $247.62K | (m) |
| 2018-03-31 | (m) | $1.12M | $14.12M | (m) | $151.44K | $237.88K | (m) |
| 2017-12-31 | (m) | $1.49M | $12.96M | (m) | $297.04K | $201.16K | (m) |
| 2017-09-30 | (m) | $1.89M | $4.96M | (m) | $225.93K | $123.35K | (m) |
| 2017-06-30 | (m) | $1.98M | $7.11M | (m) | $254.03K | $123.03K | (m) |
| 2017-03-31 | (m) | (m) | $797.17K | (m) | (m) | (m) | (m) |
| 2016-12-31 | (m) | $3.00M | $797.17K | (m) | $114.51K | $82.44K | (m) |
| 2016-09-30 | (m) | (m) | $493.21K | (m) | (m) | (m) | (m) |
| 2016-06-30 | (m) | (m) | $644.16K | (m) | (m) | (m) | (m) |
| 2016-03-31 | (m) | (m) | $1.04M | (m) | (m) | (m) | (m) |
| 2015-12-31 | (m) | (m) | $1.04M | (m) | (m) | (m) | (m) |
(m) means missing inputs. Historical market-based ratios use the saved close on or immediately before period ending and that period’s reported shares; current quotes are not substituted. Five-year projections repeat historical CAGR, not analyst forecasts.
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Envoy Medical, Inc. (COCH) | United States | $0.056B | |
| ALPHA PRO TECH LTD (APT) | $0.052B | 13.63 | |
| Safe Pro Group Inc. (SPAI) | United States | $0.090B | |
| MILESTONE SCIENTIFIC INC. (MLSS) | United States | $0.036B | -6.85 |
| LAKELAND INDUSTRIES INC (LAKE) | United States | $0.104B | -4.21 |
| NutriBand Inc. (NTRB) | United States | $0.109B | |
| Lifeward Ltd. (LFWD) | $0.021B | ||
| Conexeu Sciences Inc. (CNXU) | United States | $0.111B | |
| ENvue Medical, Inc. (FEED) | United States | $0.011B | |
| Bone Biologics Corp (BBLG) | United States | $0.001B |